Table: q1_q4_2023_prescription_drugs_intro_to_market , manufacturer_name like F*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

manufacturer_name ndc_number drug_product_description drug_category drug_category_source date_introduced_to_market wac_at_introduction marketing_pricing_plan_description marketing_pricing_plan_non_public_indicator estimated_number_of_patients breakthrough_therapy_indicator priority_review_indicator acquisition_date acquisition_price acquisition_price_non_public_indicator acquisition_price_comment general_comments supporting_documents
Ferring Pharmaceuticals 55566980010 REBYOTA (Fecal microbiota, live -jslm) Brand FDA 2023-01-23 9000.0000 None 1 4500 1 1 None None None None REBYOTA was not acquired. Comment regarding estimated patients: Ferring estimates the annual patient estimate to be in the range of 4,000-5,000. This patient estimate is based on a national annual projection for the product based on disease state and indication. We do not have estimates for individual states at this time. None
Ferring Pharmaceuticals 55566105001 ADSTILADRIN® (nadofaragene firadenovec-vncg), 4 x 80 mL Intravesical Suspension, Vial Brand FDA 2023-09-05 60000.0000 None 1 8500 1 1 None None None None Adstiladrin was not acquired. Comment regarding estimated patients: Based on current supply constraints, Ferring is capable of supplying Adstiladrin to approximately 400 patients in 2023 and 900 patients in 2024. Overall market when supply constraint is lifted in 2025 will be 8-9k patients per year. This patient estimate is based on a national annual projection for the product based on disease state and indication. We do not have estimates for individual states at this time. https://reports.siera.hcai.ca.gov/api/report/drug-pricing/attachment?id=710
Florida Pharmaceutical Products, LLC 71921017706 Purple oval shaped, biconvex bevel edged film-coated tablets, debossed with "A" on one side and "500" on the other side Generic FDA 2023-05-08 1800.0000 Since this ANDA is already generic in the US market and there are other generics available to pharmacies, there is no additional marketing plan required. Our general marketing plan for generic pharmaceuticals is to speak to buyers at wholesale distributors and retail pharmacy chains. Our pricing per bottle will be in alignment with average net pricing currently available. There is no intention to speak to prescribers. None 24000 None None None None None None None None
Fresenius Kabi USA LLC 65219037110 Stimufend Subcutaneous Solution Prefilled Syringe 6 MG/0.6ML Package Size 0.6 Package Quantity 1 Brand FDA 2023-02-08 4175.0000 None 1 1500 None None None None None None None None
Fresenius Kabi USA LLC 65219040303 Zinc Sulfate Intravenous Solution 3 MG/ML Package Size 10 Package Quantity 25 Generic FDA 2023-02-15 1050.0000 None None 83 None None None None None None None None
Fresenius Kabi USA LLC 65219040505 Zinc Sulfate Intravenous Solution 5 MG/ML Package Size 5 Package Quantity 25 Generic FDA 2023-02-15 875.0000 None None 3900 None None None None None None None None
Fresenius Kabi USA LLC 65219056420 Mitomycin intravenous solution reconstituted 5 MG 1 Vial Generic FDA 2023-03-01 243.2700 None- generic product. None 100 None None None None None None None None
Fresenius Kabi USA LLC 65219056620 mitoMYcin Intravenous Solution Reconstituted 20 MG Package Size 1 Package Quantity 1 Generic FDA 2023-03-07 631.9800 None- generic product. $0 – There was no budgeted or actual spending for direct-to-consumer or physician marketing. None 100 None None None None None None None None
Fresenius Kabi USA LLC 65219056800 mitoMYcin Intravenous Solution Reconstituted 40 MG Package Size 1 Package Quantity 1 Generic FDA 2023-03-28 1263.9600 None- generic product. $0 – There was no budgeted or actual spending for direct-to-consumer or physician marketing. None 100 None None None None None None None None
Fresenius Kabi USA LLC 63323057905 Sincalide Injection Solution Reconstituted 5 MCG Package Size 1 Package Quantity 10 Brand FDA 2023-06-20 1241.3000 None 1 800000 None None None None None None None None
Fresenius Kabi USA LLC 65219055438 Idacio for Crohns Disease/UC Subcutaneous Auto-injector Kit 40 MG/0.8ML Package Size 1 Package Quantity 3 Brand FDA 2023-07-01 19729.4700 None 1 600000 None None None None None None None None
Fresenius Kabi USA LLC 65219055428 Idacio for Plaque Psoriasis Subcutaneous Auto-injector Kit 40 MG/0.8ML Package Size 1 Package Quantity 2 Brand FDA 2023-07-01 13152.9800 None 1 600000 None None None None None None None None
Fresenius Kabi USA LLC 65219055408 Idacio Subcutaneous Auto-injector Kit 40 MG/0.8ML Package Size 1 Package Quantity 1 Brand FDA 2023-07-01 6576.4900 None 1 600000 None None None None None None None None
Fresenius Kabi USA LLC 65219055618 Idacio Subcutaneous Prefilled Syringe Kit 40 MG/0.8ML Package Size 1 Package Quantity 1 Brand FDA 2023-07-01 6576.4900 None 1 600000 None None None None None None None None
Fresenius Kabi USA LLC 65219002805 Ganirelix Acetate Subcutaneous Solution Prefilled Syringe 250 MCG/0.5ML Generic FDA 2023-07-07 216.4500 None 1 230000 None None None None None None None None
Fresenius Kabi USA LLC 65219025810 Cardioplegic Perfusion Solution Package Size 1000 ML Package Quantity 10 Generic FDA 2023-07-18 495.1000 None None 21600 None None None None None None WAC is 495.10 with a package quantity of 10 bags however a 30 day course of therapy can range from 2-20 bags. Therefore if 20 bags are needed in a 30 day course of therapy the WAC would be $990.20 None
Fresenius Kabi USA LLC 65219028412 Plerixafor Subcutaneous Solution 24 MG/1.2ML Package Size 1.2 ML Package Quantity 1 Generic FDA 2023-07-24 2990.0000 None 1 12000 None None None None None None None None
Fresenius Kabi USA LLC 65219057901 Carboprost Tromethamine Intramuscular Solution 250 MCG/ML 10 Vials Generic FDA 2023-07-25 1320.0000 None 1 20000 None None None None None None None None
Fresenius Kabi USA LLC 65219028110 Gadobutrol Intravenous Solution Package Size 10 ML Package Quantity 20 Generic FDA 2023-07-31 1162.0000 None 1 13200000 None None None None None None None None
Fresenius Kabi USA LLC 65219028107 Gadobutrol Intravenous Solution Package Size 7.5 ML Package Quantity 20 Generic FDA 2023-07-31 871.6000 None 1 13200000 None None None None None None None None
Fresenius Kabi USA LLC 65219028115 Gadobutrol Intravenous Solution Package Size 15 ML Package Quantity 20 Generic FDA 2023-07-31 1743.0000 None 1 13200000 None None None None None None None None